NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership101,694 shares
Latest Disclosed Value $ 754,569
Squarepoint Ops LLC reports 214.71% increase in ownership of NEO / NeoGenomics, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 101,694 shares of NeoGenomics, Inc. (US:NEO) valued at $754,569 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 32,314 shares of NeoGenomics, Inc.. This represents a change in shares of 214.71% during the quarter. The current value of the position is $1,031,177 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 101,694 69,380 214.71 755 98.42 0.0009
2026-02-13 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 32,314 -61,408 -65.52 380 -47.44 0.0004
2025-11-14 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 93,722 -641,751 -87.26 724 -86.55 0.0007
2025-08-27 2025-06-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 735,473 523,407 246.81 5,376 167.20 0.0056
2025-08-14 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 735,473 523,407 5,376 0.0056
2025-08-27 2025-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 212,066 195,329 1,167.05 2,013 631.64 0.0024
2025-05-15 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 212,066 195,329 2,013 0.0024
2025-02-14 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 16,737 16,737 276 0.0003
2024-11-14 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 0 -37,266 -100.00 0 -100.00
2024-08-14 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 37,266 37,266 517 0.0009
2024-05-15 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 0 -20,126 -100.00 0 -100.00
2024-02-14 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 20,126 -17,488 -46.49 326 -29.65 0.0006
2023-11-14 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 37,614 -132 -0.35 463 -23.76 0.0011
2023-08-14 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 37,746 -96,433 -71.87 607 -74.06 0.0019
2023-05-15 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 134,179 76,611 133.08 2,336 339.92 0.0095
2023-02-14 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 57,568 -189,481 -76.70 532 -75.04 0.0021
2022-11-14 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 247,049 96,329 63.91 2,127 73.21 0.0107
2022-08-15 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 150,720 -60,089 -28.50 1,228 -52.05 0.0068
2022-05-16 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 210,809 210,809 2,561 0.0110
2021-05-17 2021-03-31 13F NEOGENOMICS COM NEW 64049M209 0 -5,763 -100.00 0 -100.00
2021-02-16 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 5,763 5,763 310 0.0023
2020-02-14 2019-12-31 13F NEOGENOMICS COM NEW 64049M209 0 -78,928 -100.00 0 -100.00
2019-11-14 2019-09-30 13F NEOGENOMICS COM NEW 64049M209 78,928 61,547 354.11 1,509 296.06 0.0135
2019-08-14 2019-06-30 13F NEOGENOMICS COM NEW 64049M209 17,381 -147,916 -89.48 381 -88.73 0.0037
2019-05-15 2019-03-31 13F NEOGENOMICS COM NEW 64049M209 165,297 76,055 85.22 3,382 200.62 0.0358
2019-02-14 2018-12-31 13F NEOGENOMICS COM NEW 64049M209 89,242 8,242 10.18 1,125 -9.49 0.0131
2018-11-14 2018-09-30 13F NEOGENOMICS COM NEW 64049M209 81,000 52,500 184.21 1,243 232.35 0.0149
2018-08-14 2018-06-30 13F NEOGENOMICS COM NEW 64049M209 28,500 28,500 374 0.0050
2017-05-15 2017-03-31 13F NEOGENOMICS COM NEW 64049M209 0 -20,325 -100.00 0 -100.00
2017-02-14 2016-12-31 13F NEOGENOMICS COM NEW 64049M209 20,325 20,325 0.00 174 0.0071
2016-11-14 2016-09-30 13F NEOGENOMICS COM NEW 64049M209 0 -33,352 -100.00 0 -100.00
2016-08-15 2016-06-30 13F NEOGENOMICS COM NEW 64049M209 33,352 33,352 0.00 268 0.0167
2016-05-16 2016-03-31 13F NEOGENOMICS COM NEW 64049M209 0 -21,200 -100.00 0 -100.00
2016-02-16 2015-12-31 13F NEOGENOMICS COM NEW 64049M209 21,200 21,200 167 0.0183
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.